International Vaccine Institute
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.ivi.int
Safety and Immunogenicity of a New Formulation of Euvichol®
Phase 3
- Conditions
- Cholera
- Interventions
- Biological: Test Oral Cholera VaccineBiological: Euvichol®
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2015-12-17
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 442
- Registration Number
- NCT02502331
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Phase 1
Completed
- Conditions
- PoliomyelitisTropical Enteropathy
- Interventions
- Biological: IPV vaccination
- First Posted Date
- 2012-04-05
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 372
- Registration Number
- NCT01571505
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Diseases, Kolkata, India
Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
Phase 4
Completed
- Conditions
- CholeraVibrio Cholerae
- Interventions
- Biological: PlaceboBiological: Killed Bivalent (O1 and O139) whole cell oral cholera vaccine
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 216
- Registration Number
- NCT01524640
- Locations
- 🇪🇹
Armauer Hansen Research Institute, Addis Ababa, Oromia, Ethiopia
Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine
- Conditions
- Cholera
- First Posted Date
- 2012-01-12
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 240
- Registration Number
- NCT01508507
- Locations
- 🇮🇳
Regional Medical Research Center, Chandrashekharpur, Bhubaneswar, Odisha, India
Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: Influenza vaccine
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01488188
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Pilot Introduction of Oral Cholera Vaccine in Orissa, India
Completed
- Conditions
- Cholera
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 31552
- Registration Number
- NCT01365442
- Locations
- 🇮🇳
Regional Medical Research Center, Chandrashekharpur, Bhubaneswar, Orissa, India
Study of Alternative Vaccination Schedule of Oral Cholera Vaccine
Phase 2
Completed
- Conditions
- Vibrio InfectionCholeraDiarrhoea
- Interventions
- Biological: Modified killed oral cholera vaccine at 14 day intervalBiological: Modified killed oral cholera vaccine at 28 day interval
- First Posted Date
- 2010-11-03
- Last Posted Date
- 2013-09-25
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 386
- Registration Number
- NCT01233362
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
Phase 4
Completed
- Conditions
- Vibrio Cholerae
- Interventions
- Biological: killed bivalent (O1 and O139)whole cell oral cholera vaccine
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2014-06-17
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 200
- Registration Number
- NCT00760825
- Locations
- 🇮🇳
Christian Medical College, Vellore, Tamil Nadu, India
Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Phase 2
Completed
- Conditions
- CholeraVibrio InfectionsDiarrhea
- Interventions
- Biological: CholeraGarde®Biological: Placebo
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 32
- Registration Number
- NCT00741637
- Locations
- 🇹🇭
Department of Preventive and Social Medicine Siriraj Hospital, Bangkok, Thailand
Mass Oral Cholera Vaccination in Zanzibar
Not Applicable
Completed
- Conditions
- CholeraDiarrhea
- Interventions
- Biological: rBS-WC vaccine
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 51151
- Registration Number
- NCT00709410
- Locations
- 🇹🇿
Ministry of Health and Social Welfare, Zanzibar, Zanzibar, Tanzania
© Copyright 2025. All Rights Reserved by MedPath